A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

Clinical trial NCT00532779 · COMPLETED

Trial details

NCT number: NCT00532779
Sponsor: Orexigen Therapeutics, Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight

Start date: 2007-10-01
Primary completion: 2009-05-01
Enrollment: 1742

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.